tiprankstipranks
Trending News
More News >
Renalytix (RENXF)
OTHER OTC:RENXF

Renalytix (RENXF) Stock Statistics & Valuation Metrics

Compare
7 Followers

Total Valuation

Renalytix has a market cap or net worth of $35.24M. The enterprise value is ―.
Market Cap$35.24M
Enterprise Value

Share Statistics

Renalytix has 331,206,020 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding331,206,020
Owned by Insiders
Owned by Institutions

Financial Efficiency

Renalytix’s return on equity (ROE) is 4.26 and return on invested capital (ROIC) is -4348.24%.
Return on Equity (ROE)4.26
Return on Assets (ROA)-4.20
Return on Invested Capital (ROIC)-4348.24%
Return on Capital Employed (ROCE)8.40
Revenue Per Employee22.44K
Profits Per Employee-328.00K
Employee Count102
Asset Turnover0.29
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Renalytix is -0.45. Renalytix’s PEG ratio is -0.03.
PE Ratio-0.45
PS Ratio0.00
PB Ratio-7.57
Price to Fair Value-1.92
Price to FCF-1.53
Price to Operating Cash Flow-0.45
PEG Ratio-0.03

Income Statement

In the last 12 months, Renalytix had revenue of 2.29M and earned -33.46M in profits. Earnings per share was -0.31.
Revenue2.29M
Gross Profit156.00K
Operating Income-29.61M
Pretax Income-33.45M
Net Income-33.46M
EBITDA-28.52M
Earnings Per Share (EPS)-0.31

Cash Flow

In the last 12 months, operating cash flow was -23.02M and capital expenditures -1.00K, giving a free cash flow of -18.16M billion.
Operating Cash Flow-23.02M
Free Cash Flow-18.16M
Free Cash Flow per Share-0.05

Dividends & Yields

Renalytix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.14
52-Week Price Change-72.73%
50-Day Moving Average0.09
200-Day Moving Average0.12
Relative Strength Index (RSI)36.75
Average Volume (3m)0.00

Important Dates

Renalytix upcoming earnings date is Jun 17, 2025, TBA Not Confirmed.
Last Earnings DateMar 18, 2025
Next Earnings DateJun 17, 2025
Ex-Dividend Date

Financial Position

Renalytix as a current ratio of 0.53, with Debt / Equity ratio of -599.34%
Current Ratio0.53
Quick Ratio0.53
Debt to Market Cap0.56
Net Debt to EBITDA-0.14
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Renalytix has paid 4.00K in taxes.
Income Tax4.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Renalytix EV to EBITDA ratio is -0.66, with an EV/FCF ratio of -0.63.
EV to Sales8.26
EV to EBITDA-0.66
EV to Free Cash Flow-0.63
EV to Operating Cash Flow-0.63

Balance Sheet

Renalytix has $9.63M in cash and marketable securities with $8.21M in debt, giving a net cash position of -$1.42M billion.
Cash & Marketable Securities$9.63M
Total Debt$8.21M
Net Cash-$1.42M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.07

Margins

Gross margin is 19.73%, with operating margin of -1293.49%, and net profit margin of -1461.60%.
Gross Margin19.73%
Operating Margin-1293.49%
Pretax Margin-1461.42%
Net Profit Margin-1461.60%
EBITDA Margin-1246.00%
EBIT Margin-1261.90%

Analyst Forecast

The average price target for Renalytix is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis